Live from the NIH registry
Studies recruiting near Sioux Falls right now
Top 25 of 268 recruiting studies, sorted by proximity — each links to its official registry page
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Multiple conditions
N/A
Observational 20,000 participants sought
Sanford Health — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Sanford Health
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Avera McKennan Hospital ( Site 0002) — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK
Dry Eye
Phase 4
Interventional 60 participants sought
Vance Thompson Vision Clinic, Prof. LLC — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Vance Thompson Vision
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Avera Cancer Institute Research — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Immuneering Corporation
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Retroperitoneal Sarcoma, Liposarcoma
Phase 3
Interventional 250 participants sought
Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Sanford Cancer Center — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Eli Lilly and Company
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: NRG Oncology
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: NRG Oncology
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Sanford USD Medical Center - Sioux Falls — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Sanford Cancer Center Oncology Clinic — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: NRG Oncology
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
Extensive Stage Small Cell Lung Cancer
Phase 1
Interventional 380 participants sought
Avera Cancer Institute — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Amgen
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Vulvar Cancer, Sentinel Lymph Node
Phase 2
Interventional 157 participants sought
Avera Cancer Institute — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: University Medical Center Groningen
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Avera Cancer Institute — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Gilead Sciences
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
North Central Heart - A Division of Avera Heart Hospital — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Nectero Medical, Inc.
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Avera Medical Group Gynecologic Oncology Sioux Falls — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Daiichi Sankyo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Breast Neoplasms, Breast Cancer
Phase 2
Interventional 5,000 participants sought
Sanford Clinical Research — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: QuantumLeap Healthcare Collaborative
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Sanford USD Medical Center - Sioux Falls — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
The Minimalist Trial-2
HPV-Related Oropharynx Squamous Cell Carcinoma
Phase 2
Interventional 142 participants sought
Sanford Cancer Center — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Washington University School of Medicine
Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study
Rotator Cuff Tears
N/A
Observational 3,500 participants sought
Orthopedic Institute — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: University of Michigan
Midwest Birth Outcomes and Indigenous American Pregnancy
Pregnancy
N/A
Observational 80 participants sought
Sanford Health — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Sanford Health
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Sanford Research — Sioux Falls, South Dakota (0.3 mi)
· Sponsor: Novo Nordisk A/S